Breaking News, Promotions & Moves

VIVUS Appoints New President

Ken Suh was previously president and CEO of a wholly-owned subsidiary of VIVUS, Willow Biopharma

VIVUS announced the appointment of Ken Suh to the position of president.  Previously, Mr. Suh was president and chief executive officer of Willow Biopharma Inc., a wholly-owned subsidiary of VIVUS, Inc. As president of VIVUS, Mr. Suh will work to advance the Company toward its core objectives of product portfolio optimization and enterprise value creation.    Mr. Suh founded Willow Biopharma in 2015, and in April 2018, Willow Biopharma became a wholly-owned subsidiary of VIVUS. Prior to establ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters